These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5878705)

  • 41. Proceedings: New aspects of tryptophan metabolism in untreated phenylketonuria and the urinary indole excretion in relation to phenylalanine content of semi-synthetic diets.
    Kochen W; Byrd DJ; Schürrle L
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1218. PubMed ID: 4461534
    [No Abstract]   [Full Text] [Related]  

  • 42. [The intellectual defect in phenylketonuria, its dynamics and structure].
    Bliumina MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(2):276-80. PubMed ID: 5019829
    [No Abstract]   [Full Text] [Related]  

  • 43. [Biogenic amine metabolism in patients with oligophrenia of different origins].
    Bulakhova LA; Usherenko LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1563-7. PubMed ID: 6229120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical consequences of heterozygosity for autosomal-recessive diseases.
    Vogel F
    Clin Genet; 1984 May; 25(5):381-415. PubMed ID: 6373070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relationship between the severity of brain damage in phenylketonuria and the degree of hyperphenylalaninemia].
    Bliumina MG; Lebedev BV; Kopylova NV; Sitnichenko EI; Gerasimova NS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(12):1778-81. PubMed ID: 7223198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tryptophan metabolism in a patient with phenylketonuria and scleroderma: a proposed explanation of the indole defect in phenylketonuria.
    Drummond KN; Michael AF; Good RA
    Can Med Assoc J; 1966 Apr; 94(16):834-8. PubMed ID: 5929533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An exceptional Albanian family with seven children presenting with dysmorphic features and mental retardation: maternal phenylketonuria.
    Knerr I; Zschocke J; Schellmoser S; Topf HG; Weigel C; Dötsch J; Rascher W
    BMC Pediatr; 2005 Apr; 5(1):5. PubMed ID: 15811181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study of the metabolism of an enzymatic system in phenylketonuria].
    Goncerzewicz M
    Rev Med Liege; 1966 Jan; 21(1):1-6. PubMed ID: 5901976
    [No Abstract]   [Full Text] [Related]  

  • 49. Phenylketonuria, the inborn errors of metabolism, and clinical research--1971.
    Epstein CJ
    Calif Med; 1971 Jul; 115(1):76-9. PubMed ID: 5566345
    [No Abstract]   [Full Text] [Related]  

  • 50. [Changes in metabolism of tryptophan of a familial type with mental deficiency].
    Giovannini M; Careddu P
    Pediatria (Napoli); 1967; 75(1):48-59. PubMed ID: 5601245
    [No Abstract]   [Full Text] [Related]  

  • 51. [Maternal phenylketonuria].
    Rittinger O; Plöchl E; Jarosch E
    Padiatr Padol; 1984; 19(1):87-92. PubMed ID: 6701000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hyperphenylalaninemia].
    Hyánek J; Seemanová E; Sádlová I; Mrastíková H; Wünschová N; Hoza J; Zelingerová J
    Cas Lek Cesk; 1971; 110(15):337-41. PubMed ID: 5554915
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effectiveness of treatment of phenylketonuria in a mentally retarded 2-year-old boy].
    Loazyńska B; Siwińska A
    Wiad Lek; 1981 Jul; 34(14):1211-6. PubMed ID: 7331322
    [No Abstract]   [Full Text] [Related]  

  • 54. [Atypical forms of phenylketonuria (PKU), cause of mental deficiency].
    Repciuc E; Mogoş-Tănase I; Ionescu S; Ionescu D
    Neurol Psihiatr Neurochir; 1965; 10(5):453-61. PubMed ID: 5862295
    [No Abstract]   [Full Text] [Related]  

  • 55. Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood.
    Güttler F
    Acta Paediatr Scand Suppl; 1980; 280():1-80. PubMed ID: 7006308
    [No Abstract]   [Full Text] [Related]  

  • 56. [Tryptophan metabolism in infants with phenylketonuria].
    Bührdel P; Grimm U; Wässer S; Knapp A; Wulff K
    Padiatr Grenzgeb; 1982; 21(4):309-17. PubMed ID: 7177669
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasma phenylalanine in patients with phenylketonuria self-managing their diet.
    Bekhof J; van Rijn M; Sauer PJ; Ten Vergert EM; Reijngoud DJ; van Spronsen FJ
    Arch Dis Child; 2005 Feb; 90(2):163-4. PubMed ID: 15665170
    [No Abstract]   [Full Text] [Related]  

  • 58. Metabolic disorders and mental retardation.
    Kahler SG; Fahey MC
    Am J Med Genet C Semin Med Genet; 2003 Feb; 117C(1):31-41. PubMed ID: 12561056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Annual meeting of the Society for the Study of Inborn Errors of Metabolism. Liverpool, 3-6 September 1985.
    J Inherit Metab Dis; 1986; 9 Suppl 2():157-335. PubMed ID: 3095584
    [No Abstract]   [Full Text] [Related]  

  • 60. PKU (PHENYLKETONURIA).
    NICKEY LN
    Southwest Med; 1964 Dec; 45():385-9. PubMed ID: 14232719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.